160 related articles for article (PubMed ID: 12081011)
1. Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease.
Glass WG; Chen BP; Liu MT; Lane TE
Viral Immunol; 2002; 15(2):261-72. PubMed ID: 12081011
[TBL] [Abstract][Full Text] [Related]
2. Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS.
Stiles LN; Hosking MP; Edwards RA; Strieter RM; Lane TE
Eur J Immunol; 2006 Mar; 36(3):613-22. PubMed ID: 16479546
[TBL] [Abstract][Full Text] [Related]
3. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis.
Glass WG; Hickey MJ; Hardison JL; Liu MT; Manning JE; Lane TE
J Immunol; 2004 Apr; 172(7):4018-25. PubMed ID: 15034013
[TBL] [Abstract][Full Text] [Related]
4. Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease.
Glass WG; Lane TE
J Virol; 2003 Jan; 77(1):191-8. PubMed ID: 12477824
[TBL] [Abstract][Full Text] [Related]
5. Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system.
Ramos SJ; Hardison JL; Stiles LN; Lane TE; Walsh CM
Autoimmunity; 2007 Feb; 40(1):54-65. PubMed ID: 17364498
[TBL] [Abstract][Full Text] [Related]
6. Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease.
Lane TE; Asensio VC; Yu N; Paoletti AD; Campbell IL; Buchmeier MJ
J Immunol; 1998 Jan; 160(2):970-8. PubMed ID: 9551936
[TBL] [Abstract][Full Text] [Related]
7. CCR1 deficiency increases susceptibility to fatal coronavirus infection of the central nervous system.
Hickey MJ; Held KS; Baum E; Gao JL; Murphy PM; Lane TE
Viral Immunol; 2007 Dec; 20(4):599-608. PubMed ID: 18158733
[TBL] [Abstract][Full Text] [Related]
8. MHV infection of the CNS: mechanisms of immune-mediated control.
Marten NW; Stohlman SA; Bergmann CC
Viral Immunol; 2001; 14(1):1-18. PubMed ID: 11270593
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system.
Glass WG; Lane TE
Virology; 2003 Aug; 312(2):407-14. PubMed ID: 12919745
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma is required for viral clearance from central nervous system oligodendroglia.
Parra B; Hinton DR; Marten NW; Bergmann CC; Lin MT; Yang CS; Stohlman SA
J Immunol; 1999 Feb; 162(3):1641-7. PubMed ID: 9973424
[TBL] [Abstract][Full Text] [Related]
11. Chemokine expression and viral infection of the central nervous system: regulation of host defense and neuropathology.
Liu MT; Lane TE
Immunol Res; 2001; 24(2):111-9. PubMed ID: 11594450
[TBL] [Abstract][Full Text] [Related]
12. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus.
Xue S; Perlman S
Virology; 1997 Nov; 238(1):68-78. PubMed ID: 9375010
[TBL] [Abstract][Full Text] [Related]
13. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination.
Lane TE; Liu MT; Chen BP; Asensio VC; Samawi RM; Paoletti AD; Campbell IL; Kunkel SL; Fox HS; Buchmeier MJ
J Virol; 2000 Feb; 74(3):1415-24. PubMed ID: 10627552
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis.
Liu MT; Keirstead HS; Lane TE
J Immunol; 2001 Oct; 167(7):4091-7. PubMed ID: 11564831
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM.
Templeton SP; Perlman S
Immunol Res; 2007; 39(1-3):160-72. PubMed ID: 17917063
[TBL] [Abstract][Full Text] [Related]
16. High-magnitude, virus-specific CD4 T-cell response in the central nervous system of coronavirus-infected mice.
Haring JS; Pewe LL; Perlman S
J Virol; 2001 Mar; 75(6):3043-7. PubMed ID: 11222733
[TBL] [Abstract][Full Text] [Related]
17. Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease.
Skinner D; Marro BS; Lane TE
Viral Immunol; 2019; 32(1):25-37. PubMed ID: 30109979
[TBL] [Abstract][Full Text] [Related]
18. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system.
Bergmann CC; Altman JD; Hinton D; Stohlman SA
J Immunol; 1999 Sep; 163(6):3379-87. PubMed ID: 10477608
[TBL] [Abstract][Full Text] [Related]
19. Functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system.
Lane TE; Hardison JL; Walsh KB
Curr Top Microbiol Immunol; 2006; 303():1-27. PubMed ID: 16570854
[TBL] [Abstract][Full Text] [Related]
20. Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system.
Marten NW; Stohlman SA; Smith-Begolka W; Miller SD; Dimacali E; Yao Q; Stohl S; Goverman J; Bergmann CC
J Immunol; 1999 Apr; 162(7):3905-14. PubMed ID: 10201909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
